Treatment of gastroparesis: an update.

Vivek Gumaste, Joel Baum

Journal: Digestion 2009;78(4):173-9

PMID: 19092243

Full Text on S. Karger AG, Basel, Switzerland View on PubMed

Abstract

Gastroparesis is a chronic disorder of gastric motility that is characterized by delayed emptying of either solids or liquids from the stomach in the absence of any mechanical obstruction. Nausea, vomiting, early satiety and bloating are some of the manifestations of gastroparesis. Idiopathic, diabetes mellitus and postsurgical states account for the majority of cases. Gastroparesis is a difficult condition to treat. Prokinetic drugs like metoclopramide and erythromycin form the mainstay of therapy but are less than ideal. Some patients may benefit from endoscopic botolinium toxin injection. Gastric electrical stimulation, though promising, is not ready for prime time yet.

Address: Department of Medicine, Mount Sinai Services at Elmhurst, Elmhurst General Hospital, Elmhurst, N.Y., USA. [email protected]

DOI: 10.1159/000185690

Link outs

Free resources

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

https://doi.org/10.1159/000185690

MeSH Terms: Antiemetics, Diet Therapy, Dopamine Antagonists, Electric Stimulation Therapy, Endoscopy, Gastroparesis, Humans, Nutritional Support, Psychotherapy, Receptors, Gastrointestinal Hormone, Receptors, Neuropeptide, Serotonin 5-HT4 Receptor Agonists, Severity of Illness Index